Literature DB >> 6436639

The gonadotropin-suppressive activity of androgen is increased in elderly men.

S J Winters, R J Sherins, P Troen.   

Abstract

The influence of aging on the responsiveness to sex steroid hormones in men was studied by comparing circulating gonadotropin concentrations, pulsatile LH release, and sex hormone-binding globulin (TeBG) levels. This was done before and during a four-day continuous infusion of testosterone (T) (7.5 mg/d), dihydrotestosterone (DHT) (7.0 mg/d), or estradiol (E2) (45 micrograms/d) in young adult men, ages 18 to 32, and healthy elderly men, ages 65 to 80. DHT reduced mean serum LH and FSH levels as well as the frequency of spontaneous LH secretory episodes to a greater extent (p less than 0.05) in old men than in young men. T administration also reduced serum LH levels more in aged than in young men (P less than 0.05); however, this difference was less pronounced than for DHT. During T infusion, the decrease in serum FSH levels was similar in the two groups. Spontaneous LH pulse amplitude also declined during both T and DHT infusion in aged, but not in young men. By contrast, infusion of E2 reduced both serum LH and FSH levels comparably in aged and young men. DHT infusion also reduced serum TeBG levels equally in old and young men. Finally, each steroid infusion produced comparable mean circulating levels of T, DHT, and E2 in both groups. These data indicate that elderly men are more responsive than are young men to the gonadotropin-suppressive effects of androgen, but not to DHT effects on circulating TeBG levels. The more pronounced deceleration of spontaneous LH secretory episodes during DHT infusion in aged men provides evidence for an alteration in hypothalamic function in male senescence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436639     DOI: 10.1016/0026-0495(84)90237-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

1.  Noninvasive analytical estimation of endogenous GnRH drive: analysis using graded competitive GnRH-receptor antagonism and a calibrating pulse of exogenous GnRH.

Authors:  Daniel M Keenan; Iain J Clarke; Johannes D Veldhuis
Journal:  Endocrinology       Date:  2011-10-25       Impact factor: 4.736

2.  Graded inhibition of pulsatile luteinizing hormone secretion by a selective gonadotropin-releasing hormone (GnRH)-receptor antagonist in healthy men: evidence that age attenuates hypothalamic GnRH outflow.

Authors:  Paul Y Takahashi; Peter Y Liu; Pamela D Roebuck; Ali Iranmanesh; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

3.  Short-term aromatase-enzyme blockade unmasks impaired feedback adaptations in luteinizing hormone and testosterone secretion in older men.

Authors:  Johannes D Veldhuis; Ali Iranmanesh
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

4.  Testosterone's short-term positive effect on luteinizing-hormone secretory-burst mass and its negative effect on secretory-burst frequency are attenuated in middle-aged men.

Authors:  Peter Y Liu; Paul Y Takahashi; Pamela D Roebuck; Joy N Bailey; Daniel M Keenan; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

5.  LH isoform profiles during short-term pulsatile LHRH administration in elderly men.

Authors:  M Giusti; S Valenti; R Guido; C M Cuttica; L Foppiani; G Giordano
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

6.  Effect of pulsatile luteinizing hormone-releasing hormone administration on pituitary-gonadal function in elderly man.

Authors:  M Giusti; G Marini; L Traverso; P Cavagnaro; L Granziera; G Giordano
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

Review 7.  The andropause: fact or fiction?

Authors:  N Burns-Cox; C Gingell
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

Review 8.  Mechanisms of age-related endocrine alterations. Part II.

Authors:  A D Mooradian
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

Review 9.  Risks versus benefits of testosterone therapy in elderly men.

Authors:  S Basaria; A S Dobs
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 10.  Age-related changes in male gonadal function. Implications for therapy.

Authors:  D Maas; A Jochen; B Lalande
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.